Winslow, Evans & Crocker, Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 258 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Winslow, Evans & Crocker, Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$13,000
+18.2%
750.0%0.00%
-33.3%
Q3 2020$11,000
-8.3%
750.0%0.00%0.0%
Q2 2020$12,000
+50.0%
75
-1.3%
0.00%0.0%
Q1 2020$8,000
-20.0%
760.0%0.00%0.0%
Q4 2019$10,000
+66.7%
760.0%0.00%
+50.0%
Q3 2019$6,000
-50.0%
760.0%0.00%
-33.3%
Q2 2019$12,000
+20.0%
760.0%0.00%0.0%
Q1 2019$10,0000.0%760.0%0.00%0.0%
Q4 2018$10,000
-28.6%
760.0%0.00%
-25.0%
Q3 2018$14,000
-91.4%
76
-93.7%
0.00%
-92.2%
Q2 2018$162,000
-99.9%
1,210
-42.4%
0.05%
+2.0%
Q1 2018$155,590,000
+179.6%
2,100
+110.0%
0.05%
+177.8%
Q4 2017$55,640,000
+22.7%
1,0000.0%0.02%
+20.0%
Q3 2017$45,360,000
+34.6%
1,0000.0%0.02%
+66.7%
Q2 2017$33,710,000
-12.4%
1,000
-23.1%
0.01%
-25.0%
Q1 2017$38,480,000
-29.9%
1,300
-35.0%
0.01%
-29.4%
Q4 2016$54,860,000
-86.9%
2,000
-51.5%
0.02%
-71.7%
Q3 2016$417,588,0004,1260.06%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders